Clinical Trial Update: Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

View source ↗

Summary

An Emory University-led trial is exploring how dietary patterns and the fecal microbiome affect response to neoadjuvant chemotherapy in patients with pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Ductal Adenocarcinoma
• Pancreatic Cancer
• Resectable Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Emory University | Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | Status: RECRUITING